During the past decade, Profil Institute for Clinical Research, Inc. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 17 clinical trials were completed, i.e. on average, 212.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Profil Institute for Clinical Research, Inc." #1 sponsor was "Pfizer" with 8 trials, followed by "Wockhardt" with 5 trials sponsored, "Halozyme Therapeutics" with 4 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Profil Institute for Clinical Research, Inc." #1 collaborator was "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Profil Institute for Clinical Research, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Profil Institute for Clinical Research, Inc." are "Diabetes Mellitus, Type 2" (7 trials), "Type 2 Diabetes Mellitus" (5 trials), "Diabetes Mellitus" (4 trials), "Bioequivalence in Healthy Subjects" (3 trials) and "Diabetes" (2 trials). Many other conditions were trialed in "Profil Institute for Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Profil Institute for Clinical Research, Inc." are "Drug" (24 trials), "Biological" (8 trials), "Other" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Insulin Lispro" (4 trials), "Recombinant human hyaluronidase PH20 (rHuPH20)" (3 trials), "Dapagliflozin" (2 trials) and "Humalog" (2 trials). Other intervention names were less common.

The vast majority of trials in "Profil Institute for Clinical Research, Inc." are 31 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Profil Institute for Clinical Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Profil Institute for Clinical Research, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Profil Institute for Clinical Research, Inc., 25 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".